PMC:7253233 / 2440-2678 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"108","span":{"begin":82,"end":91},"obj":"Disease"},{"id":"109","span":{"begin":153,"end":161},"obj":"Disease"}],"attributes":[{"id":"A108","pred":"tao:has_database_id","subj":"108","obj":"MESH:D004827"},{"id":"A109","pred":"tao:has_database_id","subj":"109","obj":"MESH:D012640"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"phalopathy may benefit from electroencephalography monitoring and/or empiric anti-epileptic therapy. Further studies are needed to elucidate the risk of seizures and benefit of monitoring in this population.\n\nIntroduction\nSevere acute res"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T19","span":{"begin":153,"end":161},"obj":"Phenotype"}],"attributes":[{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0001250"}],"text":"phalopathy may benefit from electroencephalography monitoring and/or empiric anti-epileptic therapy. Further studies are needed to elucidate the risk of seizures and benefit of monitoring in this population.\n\nIntroduction\nSevere acute res"}

{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":101,"end":207},"obj":"Sentence"},{"id":"T26","span":{"begin":209,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"phalopathy may benefit from electroencephalography monitoring and/or empiric anti-epileptic therapy. Further studies are needed to elucidate the risk of seizures and benefit of monitoring in this population.\n\nIntroduction\nSevere acute res"}